Mutagen-directed Attenuation of Rift Valley Fever Virus as a Method for Vaccine Development

References

1. Barnard B. J. H., Botha M. J. 1977; An inactivated Rift Valley fever vaccine. Journal of the South African Veterinary Association 48:45–48
   [Google Scholar]
2. Bishop D. H. L., Shope R. E. 1979; Bunyaviridae. In Comprehensive Virology vol 14: pp 1–156 Edited by Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
   [Google Scholar]
3. Clewley J. P., Bishop D. H. L. 1979; Assignment of the large oligonucleotides of vesicular stomatitis virus to the N, NS, M, G and L genes and oligonucleotide gene ordering within the L gene. Journal of Virology 30:116–123
   [Google Scholar]
4. Coetzer J. A. W., Barnard B. J. H. 1977; Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with Wesselbron disease and Rift Valley fever viruses as aetiological agents. Onderstepoort Journal of Veterinary Research 44:119–126
   [Google Scholar]
5. Easterday B. C. 1965; Rift valley fever. Advances in Veterinary Research 10:65–127
   [Google Scholar]
6. Findlay G. M. 1932; Rift valley fever or enzootic hepatitis. Transactions of the Royal Society of Tropical Medicine and Hygiene 25:229–265
   [Google Scholar]
7. Moussa M. I., Wood O. L., Abdel Wahab K. S. E. 1982; Reduced pathogenicity associated with a small plaque variant of the Egyptian strain of Rift Valley fever virus (ZH501). Transactions of the Royal Society of Tropical Medicine and Hygiene 76:482–486
   [Google Scholar]
8. Peters C. J., Anderson G. W. 1981; Pathogenesis of Rift Valley fever. In Contributions to Epidemiology and Biostatistics vol 3: pp 21–41 Edited by Klingsberg M. A. Basel: S. Karger;
   [Google Scholar]
9. Peters C. J., Meegan J. M. 1984; Rift Valley fever. In CRC Handbook Series in Zoonoses vol. I pp 403–420 Edited by Beran G. W., Steele J. H. Boca Raton: CRC Press;
   [Google Scholar]
10. Randall R., Binn L. N., Harrison V. R. 1964; Immunization against Rift Valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine. Journal of Immunology 93:293–299
    [Google Scholar]
11. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent end points. American Journal of Hygiene 27:493–497
    [Google Scholar]
12. Smithburn K. C. 1949; Rift Valley fever: the neurotropic adaptation of virus and experimental use of this modified virus as a vaccine. British Journal of Experimental Pathology 30:1–16
    [Google Scholar]
13. Weinbren M. P., Williams M. C., Haddow A. J. 1957; A variant of Rift Valley fever virus. South African Medical Journal 31:951–957
    [Google Scholar]